Clinuvel Pharmaceuticals Ltd. (CUVL)
4.94
-0.09
(-1.79%)
USD |
NASDAQ |
Oct 23, 16:00
4.94
0.00 (0.00%)
After-Hours: 20:00
Clinuvel Pharmaceuticals Market Cap : 249.11M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 249.11M |
| October 22, 2026 | 253.65M |
| October 21, 2026 | 258.19M |
| October 20, 2026 | 261.72M |
| October 19, 2026 | 264.24M |
| October 16, 2026 | 263.99M |
| October 15, 2026 | 255.17M |
| October 14, 2026 | 267.27M |
| October 13, 2026 | 274.43M |
| October 12, 2026 | 281.59M |
| October 09, 2026 | 281.89M |
| October 08, 2026 | 282.40M |
| October 07, 2026 | 292.48M |
| October 06, 2026 | 285.93M |
| October 05, 2026 | 289.46M |
| October 02, 2026 | 304.08M |
| October 01, 2026 | 285.42M |
| September 30, 2026 | 300.55M |
| September 29, 2026 | 296.01M |
| September 28, 2026 | 289.96M |
| September 25, 2026 | 283.91M |
| September 24, 2026 | 291.47M |
| September 23, 2026 | 291.98M |
| September 22, 2026 | 292.48M |
| September 21, 2026 | 292.48M |
| Date | Value |
|---|---|
| September 18, 2026 | 297.52M |
| September 17, 2026 | 295.51M |
| September 16, 2026 | 297.52M |
| September 15, 2026 | 297.52M |
| September 14, 2026 | 296.01M |
| September 11, 2026 | 300.05M |
| September 10, 2026 | 296.52M |
| September 09, 2026 | 299.04M |
| September 08, 2026 | 303.07M |
| September 04, 2026 | 328.79M |
| September 03, 2026 | 316.69M |
| September 02, 2026 | 312.65M |
| September 01, 2026 | 314.67M |
| August 31, 2026 | 300.05M |
| August 28, 2026 | 310.64M |
| August 27, 2026 | 341.40M |
| August 26, 2026 | 385.48M |
| August 25, 2026 | 383.25M |
| August 24, 2026 | 374.18M |
| August 21, 2026 | 393.34M |
| August 20, 2026 | 393.34M |
| August 19, 2026 | 360.56M |
| August 18, 2026 | 347.95M |
| August 17, 2026 | 346.69M |
| August 14, 2026 | 347.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 37.88M |
| Kazia Therapeutics Ltd. | 88.53M |
| Algorae Pharmaceuticals Ltd. | 19.34M |
| Immuron Ltd. | 7.696M |
| Amplia Therapeutics Ltd. | 28.22M |
Market Cap Related Metrics
| PE Ratio | 10.74 |
| PS Ratio | 3.895 |
| PEG Ratio | 35.18 |
| Price to Free Cash Flow | 10.10 |
| Price | 4.94 |
| Earnings Yield | 9.31% |
| PEGY Ratio | 10.43 |
| Operating PE Ratio | 8.961 |
| Normalized PE Ratio | 10.74 |